HOME > 教室について > 業績リスト > 【学会発表】国際学会 > 2012年

2012年

5th IMAGING & PHYSIOLOGY Summit and 6th CHRONIC TOTAL OCCLUSION LIVE 2012 January 6-7, Seoul, Korea
  1. Junichi Tazaki, Nobuya Higashitani, Hirooki Higami, Yuko Morikami, Kentaro Nakai, Hiroki Shiomi, Masahiro Natsuaki, Masao Imai, Naritatsu Saito, Takeshi Kimura. Successful revascularization of CLI by retrograde stent implantation with Zilver Stent -Best Case Award-
ACC Scientific Session 2012, March 24 -27, Chicago, IL
  1. Junichi Tazaki, Yoshimitsu Soga, Osamu iida, Daizo Kawasaki, Yamauchi Yasutaka, Kenji Suzuki, Hirano Keisuke, Ryoji Koshida, Daisuke Kamoi, Michiaki Higashitani, Yoshiaki Shintani, Terutoshi Yamaoka, Shinya Okazaki, Nobuhiro Suematsu, Taketsugu Tsuchiya, Yusuke Miyashita, Norihiko Shinozaki, Hiroki Takahashi, Takeshi Kimura and on behalf of the REAL-AI investigators. The Effect of Statin on Aorto-iliac PAD Patients an observation from the REAL-AI registry
Angioplasty Summit TCTAP 2012, April 24 – 27, Seoul, Korea
  1. Junichi Tazaki, Nobuya Higashitani, Hirooki Higami, Yuko Morikami,Reiko Houzou,Kentaro Nakai, Hiroki Shiomi, Masahiro Natsuaki,Masao Imai, Naritatsu Saito, Takeshi Kimura. Successful Kissing stenting for LM bifurcation lesion guided by IVUS marking
25th Spring Congress of Korean Diabetes Association May 11th, 2012. Hotel Inter-Burgo Exco, Daegu
  1. Ono K. Symposium 6 (Insulin resistance) MicroRNA regulation of lipid homeostasis.
8th annual Complex Cardiovascular Catheter Therapeutics (C3): Advanced Endovascular and Coronary Intervention Global Summit 2013, June 19-23. Orlando, FL.
  1. Kimura T. Late Adverse Events After Bare-Metal and First Generation Drug Eluting Stents
European Society of Cardiology Congress 2012 August 25-29, Germany
  1. Kishimoto C, Shioji K, Yuan Z: Immunoglobulin suppressed autoimmune myocarditis in severe combined immunodeficient (SCID) mice by inducing T cell unresponsiveness.
  2. Kishimoto C, Shimada K, Yuan Z: Olmesartan, an angiotensin II type 1 receptor antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
  3. Baba O, Horie T, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, and Ono K. MicroRNA 33 Deficiency Reduces Atherosclerotic Plaque progression in ApoE Knockout Mice.
  4. Tamaki Y, Iwanaga Y, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu T, Miyazaki S, Kimura T. Interaction of S100A4 with p53 in fibroblasts modulates cardiac fibrosis through two distinct mechanisms.
  5. Kamakura T. One-year assessment of the ultrastructural changes of human induced pluripotent stem cell-derived cardiomyocytes.
  6. Ohno M, Watanabe S, Hiraoka Y, Matsuoka T, Nishi K, Saijo S, Kita T, Nishi E, Kimura T. Nardilysin, an activator of ectodomain shedding, is a novel and potent biomarker for acute coronary syndrome (Oral presentation)
  7. Ohno M, Hiraoka Y, Matsuoka T, Nishi K, Saijo S, Kita T, Kimura T, Nishi E. NRDc regulates circulatory dynamics through modulating sinus node automaticity and cardiac sympathetic innervation (Poster presentation)
  8. Kato T, Shioi T, Niizuma S, Kawashima T, Okuda J, Kawamoto A, Soga T, Kimura T. Abnormal liver metabolism and pro-inflammatory responses as modulators of cardiac cachexia in a rat model of heart failure.
  9. Kato T, Shioi T, Kawashima T, Kawamoto T, Kimura T. Mitochondrial function as a potential mediator of metabolic remodeling in the heart.
  10. Imai M, Kimura T, Kadota K , Mitsudo K. Impact of Angiographic Peri-Stent Contrast Staining (PSS) on Late Adverse Events After Sirolimus-Eluting Stent Implantation: an observation from the multicenter j-Cypher registry PSS substudy
  11. J. Tazaki, H. Horiuchi, A. Hirayama, M. Ito, S. Oshima, T. Morimoto, T. Kimura. The Efficacy of High Dose Clopidogrel for the Patient with Stable Coronary Artery Disease in Japanese Population : the primary result from the CHOICE trial
The 5th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session, Taipei, October 3 - 6, 2012. Taipei, Taiwan.
  1. Makiyama T.: Phenotypic characteristics between SCN5A and LMNA mutation carriers in familial bradyarrhythmic disorders.
  2. Kamakura T.: Genetic Backgrounds in Patients with Early-Onset and Familial Atrial Fibrillation.
  3. Sasaki K.: One Year Assessment of Ion Channel Gene Expression in Cardiomyocytes derived from Human Induced Pluripotent Stem Cells.
Transcatheter Cardiovascular Therapeutics 24th Annual Scientific Symposium October 22-26, 2012 Miami, Florida
  1. Tazaki J, Hirano K, Iida O, Kawasaki D, Kimura T, Miyashita Y, Shintani Y, Soga Y, Suematsu N, Suzuki K, Yamaoka T, Yamauchi Y. Optimal Antiplatelet Regimen for Critical Limb Ischemia due to Pure Isolated Infrapopliteal Lesions
Cold Spring Harbor Meeting (Nuclear Receptors & Diseases), Oct 30 - Nov3, 2012, Cold Spring Harbor, NY
  1. Nishi E, Hiraoka Y, Matsuoka T, Ohno M, Nishi K, Saijo S, Kita T, Kimura T. Nardilysin regulates adaptive thermogenesis via modulation of transcriptional coactivator PGC-1 (Selected for oral presentation)
American Heart Association Annual Scientific Sessions 2011, November ３ - 7, Orlando, Florida
  1. Kishimoto C, Okabe T, Shimada K, Hattori M, Murayama T, Yokode M: Swimming reduces the severity of atherosclerosis by antioxidant effects in apolipoprotein E-deficient mice.
  2. Kishimoto C, Shimada K, Murayama T, Yokode M, Fujita M: Marble-burying behavior-induced unstable plaques are stabilized by exercise training in experimental atherosclerosis.
  3. Kato T, Shioi T, Kawamoto A, Kimura T, Nagakura D, Nakane E, Miyamoto S, Izumi T, Haruna T, Inoko T, Nohara R. Tc-99m Sestamibi washout is a useful method to assess cardiac mitochondrial function and the increased risk of a failing heart: a translational approach to understand the metabolic state of the heart.
  4. Baba O, Horie T, Kuwabara Y, Izuhara M, Usami S, Nakao T, Nishiga M, Nishino T, Sowa N, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, and Ono K. MicroRNA 33 Deficiency in Leukocytes Reduced the Lipid Accumulation in Atherosclerotic Plaque in ApoE Knockout Mice.
  5. Horie T, Baba O, Ono K, Kuwabara Y, Hasegawa K, Kume N, Yokode M, Kita T, and Kimura T. MicroRNA-33 Deficiency Reduced Atherosclerosis Formation In Vivo.
  6. Nagao K, Ono K, Yamauchi Y, Tokunaga M, Fukuchi K, Uchiyama K, Ito H, Hayashi F, Makita T, Inada T, Tanaka M, Horie T, Nishi H, Kinoshita M, Kuwabara Y, Inoue K, and Kimura T. Neural Cell Adhesion Molecule is a Cardioprotective Factor Up-regulated In Rodent and Human Failing Heart
  7. Ura S, Wada H, Kitaoka S, Satoh-Asahara N, Horie T, Ono K, Takaya T, Takanabe-Mori R, Akao M, Abe M, Morimoto T, Murayama T, Yokode M, Fujita M, Shimatsu A, and Hasegawa K. Circulating Levels of Vascular Endothelial Growth Factor-C are Closely Associated with Dyslipidemia and Atherosclerosis
  8. Wada H, Ura S, Masunaga N, Akao M, Ishii M, Unoki T, Abe M, Nakajima Y, Kanasaki M, Ono K, Morimoto T, Satoh-Asahara N, Shimatsu A, and Hasegawa K. Soluble Vascular Endothelial Growth Factor Receptor-1 as a Predictor of Cardiovascular Events in Stable Outpatients with Chronic Kidney Disease
  9. Masunaga N, Wada H, Akao M, Ura S, Ishii M, Unoki T, Abe M, Kanasaki M, Nakashima Y, Ono K, Morimoto T, Asahara N, Shimatu A, and Hasegawa K. Serum Levels of Vascular Endothelial Growth Factor-C are Inversely Correlated with Future Cardiovascular Events.
  10. Ozasa　N, Morimoto T, Bao B, Shizuta S, Shiomi H, Tazaki J, Natsuaki M, Kimura T, on behalf of the CREDO-Kyoto PCI/CABG registry investigators. The Impact of Anemia on 3-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Itervention Using Drug-eluting Stent: Insights from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
ATVB Early Career Networking Reception 2012, November 6, Los Angeles, CA
  1. Horie T, Baba O, Ono K, Kuwabara Y, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T: MicroRNA-33 Deficiency Reduced Atherosclerosis Formation In Vivo.
Neuro-Vascular Wiring Symposium 2012, Nov 12-13, 2012, Nara.
  1. Ohno M, Hiraoka Y, Matsuura H, Matsuoka T, Nishi K, Saijo S, Sakamoto J, Chen PM, Kita T, Kimura T, Nishi E.　NRDc regulates circulatory dynamics through modulating sinus node automaticity and cardiac sympathetic innervation.
ASCB (American Society for Cell Biology) 2012, December 15-19, San Francisco, CA
  1. Hiraoka Y, Yoshitane H, Nunokawa R, Fukada Y, Kimura T and Nishi E. Nardilysin regulates the mammalian circadian clock via modulating PER2 stability (Poster presentation)
International Symposium on Protein Modifications in Pathogenic Dysregulation of Signaling. Feb1-2. 2013. Tokyo
  1. Nishi E. Nardilysin promotes cancer development through activation of ectodomain shedding.
ACC Scientific Session 2013, March 9 -11, San Francisco, CA
  1. Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, Kazushige Kadota, Toshiya Muramatsu, Yoshihisa Nakagawa, Takashi Akasaka, Keiichi Igarashi, Kengo Tanabe, Yoshihiro Morino, Tetsuya Ishikawa, Hideo Nishikawa, Masaki Awata, Masaharu Akao, Hisayuki Okada, Yoshiki Takatsu, Nobuhiko Ogata, Kazuo Kimura, Kazushi Urasawa, Yasuhiro Tarutani, Nobuo Shiode, Takeshi Kimura. One-Year Outcome of a Trial Comparing Second Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: The NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-Eluting Stent Trial (NEXT)
  2. Hiroki Shiomi, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Takeshi Kimura, The CREDO-Kyoto AMI Registry Investigators, Kyoto University Graduate School of Medicine, Kyoto, Japan. Long-Term Clinical Outcome in Patients with Acute Myocardial Infarction Complicating Cardiogenic Shock: Insight from the CREDO-Kyoto AMI Registry. Poster Session.
<< 2011年｜ 業績リストTOP ｜2013年 >>
ページの先頭へ